258 related articles for article (PubMed ID: 32017008)
1. The Effect of the APOE ε2ε4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non-Latino Whites.
Ren D; Lopez OL; Lingler JH; Conley Y
J Am Geriatr Soc; 2020 May; 68(5):1044-1049. PubMed ID: 32017008
[TBL] [Abstract][Full Text] [Related]
2.
Oveisgharan S; Buchman AS; Yu L; Farfel J; Hachinski V; Gaiteri C; De Jager PL; Schneider JA; Bennett DA
Neurology; 2018 Jun; 90(24):e2127-e2134. PubMed ID: 29752306
[TBL] [Abstract][Full Text] [Related]
3. Accelerated progression from mild cognitive impairment to dementia among APOE ε4ε4 carriers.
Xu WL; Caracciolo B; Wang HX; Santoni G; Winblad B; Fratiglioni L
J Alzheimers Dis; 2013; 33(2):507-15. PubMed ID: 23247007
[TBL] [Abstract][Full Text] [Related]
4. Association Between the APOEɛ2/ɛ4 Genotype and Alzheimer's Disease and Mild Cognitive Impairment Among African Americans.
Ren D; Lopez OL; Lingler JH; Conley Y
J Alzheimers Dis; 2021; 81(3):943-948. PubMed ID: 33935088
[TBL] [Abstract][Full Text] [Related]
5. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
[TBL] [Abstract][Full Text] [Related]
6. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
[TBL] [Abstract][Full Text] [Related]
7. Comparison of genetic and health risk factors for mild cognitive impairment and Alzheimer's disease between Hispanic and non-Hispanic white participants.
Xiao C; Pappas I; Aksman LM; O'Bryant SE; Toga AW;
Alzheimers Dement; 2023 Nov; 19(11):5086-5094. PubMed ID: 37104247
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
Jansen WJ; Ossenkoppele R; Knol DL; Tijms BM; Scheltens P; Verhey FR; Visser PJ; ; Aalten P; Aarsland D; Alcolea D; Alexander M; Almdahl IS; Arnold SE; Baldeiras I; Barthel H; van Berckel BN; Bibeau K; Blennow K; Brooks DJ; van Buchem MA; Camus V; Cavedo E; Chen K; Chetelat G; Cohen AD; Drzezga A; Engelborghs S; Fagan AM; Fladby T; Fleisher AS; van der Flier WM; Ford L; Förster S; Fortea J; Foskett N; Frederiksen KS; Freund-Levi Y; Frisoni GB; Froelich L; Gabryelewicz T; Gill KD; Gkatzima O; Gómez-Tortosa E; Gordon MF; Grimmer T; Hampel H; Hausner L; Hellwig S; Herukka SK; Hildebrandt H; Ishihara L; Ivanoiu A; Jagust WJ; Johannsen P; Kandimalla R; Kapaki E; Klimkowicz-Mrowiec A; Klunk WE; Köhler S; Koglin N; Kornhuber J; Kramberger MG; Van Laere K; Landau SM; Lee DY; de Leon M; Lisetti V; Lleó A; Madsen K; Maier W; Marcusson J; Mattsson N; de Mendonça A; Meulenbroek O; Meyer PT; Mintun MA; Mok V; Molinuevo JL; Møllergård HM; Morris JC; Mroczko B; Van der Mussele S; Na DL; Newberg A; Nordberg A; Nordlund A; Novak GP; Paraskevas GP; Parnetti L; Perera G; Peters O; Popp J; Prabhakar S; Rabinovici GD; Ramakers IH; Rami L; Resende de Oliveira C; Rinne JO; Rodrigue KM; Rodríguez-Rodríguez E; Roe CM; Rot U; Rowe CC; Rüther E; Sabri O; Sanchez-Juan P; Santana I; Sarazin M; Schröder J; Schütte C; Seo SW; Soetewey F; Soininen H; Spiru L; Struyfs H; Teunissen CE; Tsolaki M; Vandenberghe R; Verbeek MM; Villemagne VL; Vos SJ; van Waalwijk van Doorn LJ; Waldemar G; Wallin A; Wallin ÅK; Wiltfang J; Wolk DA; Zboch M; Zetterberg H
JAMA; 2015 May; 313(19):1924-38. PubMed ID: 25988462
[TBL] [Abstract][Full Text] [Related]
9. Associations between apolipoprotein E gene polymorphisms and Alzheimer's disease risk in a large Chinese Han population.
Wu P; Li HL; Liu ZJ; Tao QQ; Xu M; Guo QH; Hong Z; Sun YM
Clin Interv Aging; 2015; 10():371-8. PubMed ID: 25673977
[TBL] [Abstract][Full Text] [Related]
10. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
[TBL] [Abstract][Full Text] [Related]
12. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
13. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
Dunk MM; Driscoll I;
J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
[TBL] [Abstract][Full Text] [Related]
15. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
[TBL] [Abstract][Full Text] [Related]
16. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
[TBL] [Abstract][Full Text] [Related]
17. Prospective Evaluation of Cognitive Health and Related Factors in Elderly at Risk for Developing Alzheimer's Dementia: A Longitudinal Cohort Study.
Udeh-Momoh C; Price G; Ropacki MT; Ketter N; Andrews T; Arrighi HM; Brashear HR; Robb C; Bassil DT; Cohn M; Curry LK; Su B; Perera D; Giannakopoulou P; Car J; Ward HA; Perneczky R; Novak G; Middleton L
J Prev Alzheimers Dis; 2019; 6(4):256-266. PubMed ID: 31686098
[TBL] [Abstract][Full Text] [Related]
18. APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.
Qian J; Wolters FJ; Beiser A; Haan M; Ikram MA; Karlawish J; Langbaum JB; Neuhaus JM; Reiman EM; Roberts JS; Seshadri S; Tariot PN; Woods BM; Betensky RA; Blacker D
PLoS Med; 2017 Mar; 14(3):e1002254. PubMed ID: 28323826
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
20. Association of
Qian J; Betensky RA; Hyman BT; Serrano-Pozo A
Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
